Literature DB >> 8567994

Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.

P A Jackson1, M A Green, A Pouli, R Hubbard, C G Marks, M G Cook.   

Abstract

AIMS: To investigate the changes in and relations among p53, CD44 and MIB-1 expression in adenocarcinomas of the colorectum and to determine whether these changes are progressive across the adenoma-carcinoma sequence.
METHODS: Expression of p53 protein, CD44 adhesion molecule and MIB-1 proliferation antigen was detected using immunohistochemistry in 68 colorectal carcinomas and 32 colorectal adenoma. The staining characteristics were compared with degree of dysplasia in adenomas, and differentiation and Dukes' stage in carcinomas. Results were analysed and assessed using Spearman's rank correlation and independent t tests.
RESULTS: p53 staining was present in som adenomas and correlated with the degree of dysplasia. There was significantly more staining in carcinomas than adenomas and significant correlation between staining and Dukes' stage. CD44 staining was maximal in adenomas, diminished in carcinomas and was minimal in metastasising carcinomas. There was inverse correlation between p53 and CD44 expression across the adenoma-carcinoma-metastasising carcinoma sequence. MIB-1 expression was highest in carcinomas but did not correlate with either p53 or CD44 expression.
CONCLUSIONS: There are progressive changes in p53, CD44 and MIB-1 expression in adenomas and carcinomas. A combination of these tests may prove useful in assessing which patients with adenomas are at greatest risk of progressing to carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567994      PMCID: PMC503034          DOI: 10.1136/jcp.48.12.1098

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas.

Authors:  M J O'Brien; S J Winawer; A G Zauber; L S Gottlieb; S S Sternberg; B Diaz; G R Dickersin; S Ewing; S Geller; D Kasimian
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

2.  CD44 and cancer screening.

Authors:  S B Fox; K C Gatter; D G Jackson; G R Screaton; M V Bell; J I Bell; A L Harris; D Simmons; J Fawcett
Journal:  Lancet       Date:  1993-08-28       Impact factor: 79.321

3.  Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).

Authors:  E R Fisher; R Sass; A Palekar; B Fisher; N Wolmark
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

4.  A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer.

Authors:  P H Chapuis; O F Dent; R Fisher; R C Newland; M T Pheils; E Smyth; K Colquhoun
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

5.  Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.

Authors:  V J Wielenga; K H Heider; G J Offerhaus; G R Adolf; F M van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

6.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

7.  A multivariate analysis of pathologic prognostic indicators in large bowel cancer.

Authors:  T Wiggers; J W Arends; B Schutte; L Volovics; F T Bosman
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

8.  Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.

Authors:  X F Sun; J M Carstensen; H Zhang; O Stål; S Wingren; T Hatschek; B Nordenskjöld
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

9.  p53 expression and K-ras mutation in colorectal adenomas.

Authors:  N Scott; S M Bell; P Sagar; G E Blair; M F Dixon; P Quirke
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

10.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

View more
  5 in total

1.  Endothelial adhesion of synchronized gastric tumor cells changes during cell cycle transit and correlates with the expression level of CD44 splice variants.

Authors:  Anton Oertl; Jens Castein; Tobias Engl; Wolf-Dietrich Beecken; Dietger Jonas; Richard Melamed; Roman A Blaheta
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

2.  CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.

Authors:  L H Zhao; Q L Lin; J Wei; Y L Huai; K J Wang; H Y Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature.

Authors:  P Kogerman; M S Sy; L A Culp
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  CD44 and HCELL: preventing hematogenous metastasis at step 1.

Authors:  Pieter P Jacobs; Robert Sackstein
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

5.  Prognostic evaluation of metallothionein expression in human colorectal neoplasms.

Authors:  E E Ioachim; A C Goussia; N J Agnantis; M Machera; E V Tsianos; A M Kappas
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.